Illumina Inc (ILMN)

$214.67 +9.67 (4.72%)
Market Cap 28.43B
Revenue (ttm) 4.34B
Net Income (ttm) 850.00M
EPS (ttm) N/A
PE Ratio 37.50
Forward PE 36.06
Profit Margin 19.57%
Debt to Equity Ratio 0.53
Volume 1,802,883
Avg Vol 1,927,640
Day's Range N/A - N/A
Shares Out 151.00M
Stochastic %K 99%
Beta 1.45
Analysts Sell
Price Target $198.79

Company Profile

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other g...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 858 202 4500
Fax: 858 202 4766
Address:
5200 Illumina Way, San Diego, United States
M_Chromatic
M_Chromatic Aug. 20 at 4:01 PM
$ILMN Nice breakout on a tough day.
0 · Reply
tarzzanman
tarzzanman Aug. 20 at 3:27 PM
$ILMN Took just a little profits @ 219 just incase 😎
0 · Reply
WAJeff
WAJeff Aug. 20 at 3:17 PM
$ILMN 217.49 is a 52 week high during regular trading hours, it briefly touched 218 after last earnings
0 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 20 at 2:59 PM
$ILMN $TEM $CAI $NTRA PRECEISION MEDICINE PICKS AND SHOVELS
0 · Reply
JFDI
JFDI Aug. 20 at 2:57 PM
$ILMN stage 2 monsta
0 · Reply
ManuelLemon952
ManuelLemon952 Aug. 20 at 7:39 AM
$BIDU $IR $CPRT $WTW $ILMN Baidu benefits from Chinese AI and cloud demand, Ingersoll Rand benefits from industrial and energy-efficiency spending, Copart benefits from vehicle salvage and insurance activity, Willis Towers Watson benefits from insurance and advisory demand, and Illumina remains focused on genomics adoption. I'm watching Chinese AI spending, industrial orders, used-vehicle values, insurance pricing, and sequencing demand.
0 · Reply
Johnny_Lever
Johnny_Lever Aug. 20 at 4:43 AM
$ILMN Rinse and repeat!
0 · Reply
Sunnytrading90
Sunnytrading90 Aug. 19 at 8:14 PM
$ILMN trend with no friends @howardlindzon
0 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 19 at 2:35 PM
$ILMN wants that 52wh this week
0 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 19 at 2:19 PM
$MRK $MRNA.... $ILMN 'picks and shovels'
0 · Reply
Latest News on ILMN
Illumina downgraded to Hold from Buy at Freedom Broker

2026-08-05T13:56:59.000Z - 15 days ago

Illumina downgraded to Hold from Buy at Freedom Broker

Illumina price target raised to $225 from $200 at Piper Sandler

2026-08-03T11:36:53.000Z - 17 days ago

Illumina price target raised to $225 from $200 at Piper Sandler

Illumina price target raised to $205 from $190 at Canaccord

2026-08-03T11:11:28.000Z - 17 days ago

Illumina price target raised to $205 from $190 at Canaccord

Illumina price target raised to $113 from $95 at Citi

2026-08-03T10:40:55.000Z - 17 days ago

Illumina price target raised to $113 from $95 at Citi

Illumina price target raised to $230 from $170 at RBC Capital

2026-07-31T14:10:26.000Z - 20 days ago

Illumina price target raised to $230 from $170 at RBC Capital

Illumina price target raised to $210 from $192 at TD Cowen

2026-07-31T12:59:04.000Z - 20 days ago

Illumina price target raised to $210 from $192 at TD Cowen

Illumina price target raised to $140 from $120 at BofA

2026-07-31T12:37:33.000Z - 20 days ago

Illumina price target raised to $140 from $120 at BofA

Illumina price target raised to $215 from $185 at Bernstein

2026-07-31T11:57:29.000Z - 20 days ago

Illumina price target raised to $215 from $185 at Bernstein

Illumina price target raised to $225 from $155 at Stifel

2026-07-31T11:26:41.000Z - 20 days ago

Illumina price target raised to $225 from $155 at Stifel

Illumina price target raised to $230 from $220 at JPMorgan

2026-07-31T11:20:59.000Z - 20 days ago

Illumina price target raised to $230 from $220 at JPMorgan

Illumina price target raised to $226 from $200 at Guggenheim

2026-07-31T10:55:37.000Z - 20 days ago

Illumina price target raised to $226 from $200 at Guggenheim

Illumina price target raised to $160 from $145 at Barclays

2026-07-31T09:10:12.000Z - 20 days ago

Illumina price target raised to $160 from $145 at Barclays

Illumina Earnings Call Transcript: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 20 days ago

Illumina Earnings Call Transcript: Q2 2026

Illumina Earnings release: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 20 days ago

Illumina Earnings release: Q2 2026

Illumina Slides: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 20 days ago

Illumina Slides: Q2 2026

Illumina Quarterly report: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 20 days ago

Illumina Quarterly report: Q2 2026

Illumina reports Q2 adjusted EPS $1.31, consensus $1.23

2026-07-30T20:11:48.000Z - 20 days ago

Illumina reports Q2 adjusted EPS $1.31, consensus $1.23

Illumina raises FY26 adjusted EPS view to $5.30-$5.40 from $5.15-$5.30

2026-07-30T20:10:55.000Z - 20 days ago

Illumina raises FY26 adjusted EPS view to $5.30-$5.40 from $5.15-$5.30

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026

Jul 30, 2026, 4:05 PM EDT - 20 days ago

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026

Fishbone Advisors Survey: Institutional Investors See Healthcare's AI Story as Overblown

Jul 22, 2026, 6:00 AM EDT - 4 weeks ago

Fishbone Advisors Survey: Institutional Investors See Healthcare's AI Story as Overblown

Illumina price target raised to $210 from $175 at Leerink

2026-07-17T12:50:39.000Z - 4 weeks ago

Illumina price target raised to $210 from $175 at Leerink

Illumina adds three new member companies to Billion Cell Atlas alliance

2026-07-16T16:05:12.000Z - 5 weeks ago

Illumina adds three new member companies to Billion Cell Atlas alliance

Illumina expands Billion Cell Atlas program with new AI drug developers

Jul 16, 2026, 12:00 PM EDT - 5 weeks ago

Illumina expands Billion Cell Atlas program with new AI drug developers

Illumina price target raised to $192 from $140 at TD Cowen

2026-07-15T12:45:54.000Z - 5 weeks ago

Illumina price target raised to $192 from $140 at TD Cowen

Illumina price target raised to $190 from $140 at Canaccord

2026-07-14T10:56:23.000Z - 5 weeks ago

Illumina price target raised to $190 from $140 at Canaccord

Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

Jul 9, 2026, 4:05 PM EDT - 5 weeks ago

Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer

Jul 9, 2026, 9:05 AM EDT - 6 weeks ago

Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer

Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip

Jun 29, 2026, 4:07 AM EDT - 7 weeks ago

Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip

Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors

Jun 23, 2026, 9:05 AM EDT - 2 months ago

Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors

The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 2 months ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX

Illumina (ILMN): Bullish Structure Builds After Breakout

Jun 9, 2026, 5:10 PM EDT - 2 months ago

Illumina (ILMN): Bullish Structure Builds After Breakout

Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution

Jun 8, 2026, 9:15 AM EDT - 2 months ago

Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution

Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights

Jun 1, 2026, 8:58 AM EDT - 2 months ago

Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights

Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research

May 28, 2026, 12:30 PM EDT - 3 months ago

Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research

Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research

May 28, 2026, 9:15 AM EDT - 3 months ago

Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research

David P. King elected to Illumina's Board of Directors

May 21, 2026, 4:15 PM EDT - 3 months ago

David P. King elected to Illumina's Board of Directors

Illumina Transcript: AGM 2026

May 21, 2026, 1:00 PM EDT - 3 months ago

Illumina Transcript: AGM 2026

Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact

May 19, 2026, 4:30 PM EDT - 3 months ago

Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact

What CEOs from Tesla, Nvidia and over a dozen other companies hope to gain by joining Trump in China

May 13, 2026, 12:03 PM EDT - 3 months ago

What CEOs from Tesla, Nvidia and over a dozen other companies hope to gain by joining Trump in China

NVDA TSLA AAPL BA BLK BX C

Illumina Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Illumina Earnings Call Transcript: Q1 2026

Illumina Earnings release: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Illumina Earnings release: Q1 2026

Illumina Slides: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Illumina Slides: Q1 2026

Illumina Quarterly report: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Illumina Quarterly report: Q1 2026

Illumina Reports Financial Results for First Quarter of Fiscal Year 2026

Apr 30, 2026, 4:05 PM EDT - 3 months ago

Illumina Reports Financial Results for First Quarter of Fiscal Year 2026

DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

Apr 16, 2026, 9:15 AM EDT - 4 months ago

DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease

Apr 14, 2026, 9:15 AM EDT - 4 months ago

Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease

Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026

Apr 9, 2026, 4:30 PM EDT - 4 months ago

Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026

Illumina Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 4 months ago

Illumina Proxy statement: Proxy filing

Illumina Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 4 months ago

Illumina Proxy statement: Proxy filing

Illumina Announces Changes to Board of Directors

Apr 2, 2026, 9:07 AM EDT - 5 months ago

Illumina Announces Changes to Board of Directors

Illumina and Labcorp expand collaboration to broaden access to precision oncology testing

Mar 18, 2026, 9:15 AM EDT - 5 months ago

Illumina and Labcorp expand collaboration to broaden access to precision oncology testing

LH

Illumina advances preventive genomics through strategic consortium with Veritas Genetics

Mar 16, 2026, 9:15 AM EDT - 5 months ago

Illumina advances preventive genomics through strategic consortium with Veritas Genetics

Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering

Mar 5, 2026, 9:15 AM EST - 6 months ago

Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering

Illumina Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 3:10 PM EST - 6 months ago

Illumina Transcript: TD Cowen 46th Annual Health Care Conference

Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida

Feb 27, 2026, 9:15 AM EST - 6 months ago

Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida

Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026

Feb 26, 2026, 8:00 AM EST - 6 months ago

Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026

Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics

Feb 25, 2026, 9:15 AM EST - 6 months ago

Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics

Illumina launches TruPath Genome, setting a new standard in genomic insight

Feb 24, 2026, 12:15 PM EST - 6 months ago

Illumina launches TruPath Genome, setting a new standard in genomic insight

Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility

Feb 23, 2026, 9:15 AM EST - 6 months ago

Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility

Illumina To Webcast Upcoming Investor Conference

Feb 17, 2026, 3:10 PM EST - 6 months ago

Illumina To Webcast Upcoming Investor Conference

Illumina Earnings Call Transcript: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Illumina Earnings Call Transcript: Q4 2025

Illumina Annual report: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Illumina Annual report: Q4 2025

Illumina Earnings release: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Illumina Earnings release: Q4 2025

Illumina Slides: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Illumina Slides: Q4 2025

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025

Feb 5, 2026, 4:06 PM EST - 6 months ago

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025

Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally

Feb 3, 2026, 9:15 AM EST - 7 months ago

Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally

Illumina completes acquisition of SomaLogic

Jan 30, 2026, 9:05 AM EST - 7 months ago

Illumina completes acquisition of SomaLogic

Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology

Jan 20, 2026, 9:15 AM EST - 7 months ago

Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology

Illumina Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 10:30 AM EST - 7 months ago

Illumina Transcript: 44th Annual J.P. Morgan Healthcare Conference

Illumina Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 10:30 AM EST - 7 months ago

Illumina Slides: 44th Annual J.P. Morgan Healthcare Conference

Illumina unveils dataset to speed up AI-powered drug discovery

Jan 13, 2026, 9:18 AM EST - 7 months ago

Illumina unveils dataset to speed up AI-powered drug discovery

Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery

Jan 13, 2026, 9:15 AM EST - 7 months ago

Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

Jan 13, 2026, 9:00 AM EST - 7 months ago

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

Jan 12, 2026, 4:07 PM EST - 7 months ago

Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

Illumina Appoints Dr. Eric Green as Chief Medical Officer

Jan 8, 2026, 4:30 PM EST - 7 months ago

Illumina Appoints Dr. Eric Green as Chief Medical Officer

Illumina and PREMIA partner to expand clinical access to CGP in Asia

Jan 8, 2026, 8:07 AM EST - 8 months ago

Illumina and PREMIA partner to expand clinical access to CGP in Asia

Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis

Jan 6, 2026, 9:15 AM EST - 8 months ago

Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis

Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

Dec 11, 2025, 9:15 AM EST - 9 months ago

Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

Illumina Transcript: Wolfe Research Healthcare Conference 2025

Nov 19, 2025, 9:20 AM EST - 9 months ago

Illumina Transcript: Wolfe Research Healthcare Conference 2025

Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study

Nov 12, 2025, 12:00 PM EST - 10 months ago

Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study

Final Trades: Morgan Stanley, Cisco Systems, Illumina and FTAI Aviation

Nov 10, 2025, 1:16 PM EST - 10 months ago

Final Trades: Morgan Stanley, Cisco Systems, Illumina and FTAI Aviation

CSCO FTAI MS

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

Nov 10, 2025, 12:15 PM EST - 10 months ago

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

LAB

Illumina Responds to Positive Updates from Chinese Ministry of Commerce

Nov 5, 2025, 5:16 PM EST - 10 months ago

Illumina Responds to Positive Updates from Chinese Ministry of Commerce

Illumina Earnings Call Transcript: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 10 months ago

Illumina Earnings Call Transcript: Q3 2025

Illumina Quarterly report: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 10 months ago

Illumina Quarterly report: Q3 2025

Illumina Earnings release: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 10 months ago

Illumina Earnings release: Q3 2025

Illumina Slides: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 10 months ago

Illumina Slides: Q3 2025

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025

Oct 30, 2025, 4:05 PM EDT - 10 months ago

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025

Final Trades: Illumina, Columbia Banking, Alibaba and JPMorgan Chase

Oct 20, 2025, 4:21 PM EDT - 10 months ago

Final Trades: Illumina, Columbia Banking, Alibaba and JPMorgan Chase

BABA COLB JPM

Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

Oct 15, 2025, 9:15 AM EDT - 11 months ago

Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Oct 15, 2025, 9:15 AM EDT - 11 months ago

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

WGS

M_Chromatic
M_Chromatic Aug. 20 at 4:01 PM
$ILMN Nice breakout on a tough day.
0 · Reply
tarzzanman
tarzzanman Aug. 20 at 3:27 PM
$ILMN Took just a little profits @ 219 just incase 😎
0 · Reply
WAJeff
WAJeff Aug. 20 at 3:17 PM
$ILMN 217.49 is a 52 week high during regular trading hours, it briefly touched 218 after last earnings
0 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 20 at 2:59 PM
$ILMN $TEM $CAI $NTRA PRECEISION MEDICINE PICKS AND SHOVELS
0 · Reply
JFDI
JFDI Aug. 20 at 2:57 PM
$ILMN stage 2 monsta
0 · Reply
ManuelLemon952
ManuelLemon952 Aug. 20 at 7:39 AM
$BIDU $IR $CPRT $WTW $ILMN Baidu benefits from Chinese AI and cloud demand, Ingersoll Rand benefits from industrial and energy-efficiency spending, Copart benefits from vehicle salvage and insurance activity, Willis Towers Watson benefits from insurance and advisory demand, and Illumina remains focused on genomics adoption. I'm watching Chinese AI spending, industrial orders, used-vehicle values, insurance pricing, and sequencing demand.
0 · Reply
Johnny_Lever
Johnny_Lever Aug. 20 at 4:43 AM
$ILMN Rinse and repeat!
0 · Reply
Sunnytrading90
Sunnytrading90 Aug. 19 at 8:14 PM
$ILMN trend with no friends @howardlindzon
0 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 19 at 2:35 PM
$ILMN wants that 52wh this week
0 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 19 at 2:19 PM
$MRK $MRNA.... $ILMN 'picks and shovels'
0 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 19 at 1:54 PM
$ILMN on 52wh watch
0 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 19 at 1:45 PM
$ILMN 210C 2DTE
0 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 19 at 1:41 PM
$ILMN Every personalized neoantigen vaccine requires tumor plus germline sequencing to identify each patient's mutations $MRNA $MRK
0 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 19 at 1:37 PM
$ILMN is gonna re-rate on this MRK MRNA news imo
0 · Reply
tarzzanman
tarzzanman Aug. 18 at 12:20 PM
$ILMN Can we get back over 200$ this week or nah? still holding my shares from 120-165 range
0 · Reply
zero_vector
zero_vector Aug. 18 at 9:47 AM
$ILMN coiling up at the 50 day average
0 · Reply
HedgeFollow
HedgeFollow Aug. 17 at 8:31 AM
💡𝗣𝗿𝗶𝗺𝗲𝗖𝗮𝗽 13𝗙 𝗥𝗘𝗟𝗘𝗔𝗦𝗘𝗗💡 Legendary Hedge Fund manager Theofanis A. Kolokotrones submitted his latest 13F filing. 𝘔𝘰𝘴𝘵 𝘕𝘰𝘵𝘢𝘣𝘭𝘦 𝘗𝘰𝘴𝘪𝘵𝘪𝘰𝘯 𝘊𝘩𝘢𝘯𝘨𝘦𝘴: 🔹𝗡𝗲𝘄 𝗟𝗔𝗥𝗚𝗘 𝗕𝘂𝘆𝘀: $SPCX 🔹𝗔𝗱𝗱𝗲𝗱 40-50% 𝗺𝗼𝗿𝗲: $BSX and $AAL 🔹Heavily 𝗕𝗢𝗢𝗦𝗧𝗘𝗗: $ILMN 🔹𝗥𝗲𝗱𝘂𝗰𝗲𝗱 by 10-20%: Texas Inst & Micron Theo's 𝗽𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗶𝘀 𝗨𝗣 51.50% inQ2 alone! Outstanding! Source: hedgefollow.com/funds/Primecap+Management
1 · Reply
Estimize
Estimize Aug. 10 at 2:06 PM
Wall St is expecting 1.36 EPS for $ILMN Q3 [Reporting 10/29 AMC] http://www.estimize.com/intro/ilmn?chart=historical&metric_name=eps&utm_co
0 · Reply
peakbuying
peakbuying Aug. 7 at 4:50 AM
$ILMN more coming
0 · Reply
JFDI
JFDI Aug. 6 at 11:16 PM
$ILMN
1 · Reply
BrendaSaxe1022
BrendaSaxe1022 Aug. 5 at 6:48 AM
$CFG $GFI $BIIB $RDDT $ILMN Citizens Financial strengthens banking operations, Gold Fields benefits from higher gold prices, Biogen advances neurological therapies, Reddit continues improving advertising monetization, and Illumina leads genomic sequencing.
0 · Reply
GabrielBarrett973
GabrielBarrett973 Aug. 5 at 5:32 AM
$ILMN $CBOE $RMD $TDY $CFG Illumina leads genomic sequencing, Cboe Global Markets benefits from exchange activity, ResMed dominates sleep therapy, Teledyne expands industrial technology, and Citizens Financial strengthens banking operations.
0 · Reply